Challenges and pitfalls in anesthesia for electroconvulsive therapy.
anesthesia
depressive disorder
electroconvulsive therapy
general
treatment-resistant depression
Journal
Best practice & research. Clinical anaesthesiology
ISSN: 1878-1608
Titre abrégé: Best Pract Res Clin Anaesthesiol
Pays: Netherlands
ID NLM: 101121446
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
received:
25
08
2020
revised:
11
12
2020
accepted:
19
12
2020
entrez:
25
5
2021
pubmed:
26
5
2021
medline:
2
6
2021
Statut:
ppublish
Résumé
Electroconvulsive therapy (ECT) refers to the application of electricity to the patients' scalp to treat psychiatric disorders, most notably, treatment-resistant depression. It is a safe, effective, and evidence-based therapy that is performed with general anesthesia. Muscle relaxation is used to prevent injuries related to the tonic-clonic seizure caused by ECT. Hypnotics are administered to induce amnesia and unconsciousness, so that, patients do not experience the period of muscle relaxation, while the generalized seizure is left unnoticed. For the anesthesiologist, ECT is associated with the challenges and pitfalls that are related to informed consent, social acceptance of ECT, airway management (especially in COVID-19 patients), and the interaction between ventilation and anesthetics from one viewpoint, and seizure induction and maintenance from another. The exact mode of action of the therapy is as unknown as the optimal choice or combination of anesthetics used.
Identifiants
pubmed: 34030803
pii: S1521-6896(20)30136-1
doi: 10.1016/j.bpa.2020.12.012
pii:
doi:
Substances chimiques
Anesthetics
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
181-189Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest MS has received honoraria for lectures from Medtronic Inc. and MT Monitortechnik, the manufacturers of the BIS and the Narcotrend monitors, respectively. RV has received honoraria for expert board meetings from Medtronic Inc. The other authors declare no conflicts of interest.